Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to findings from a federally funded study published in Vaccine. The study looked at 167 pregnant people who received a primary or booster vaccine, which generated antibodies that crossed to the cord blood and likely conferred some protection in their newborns. Participants who received a booster dose had substantially more antibodies in their own blood and in their cord blood, suggesting that boosting increased their newborns’ immune defenses against COVID-19. 
 

Headline
The U.S. maternal mortality rate fell to 17.9 deaths per 100,000 live births in 2024, statistically similar to the 2023 rate of 18.6 per 100,000,…
Headline
The AHA and Epic are launching the Safer Births PPH Collaborative, a seven-month initiative designed to support hospitals in reducing postpartum hemorrhage…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
A new blog shares key takeaways from the AHA’s Better Health for Mothers and Babies webinar series, where hospitals share how they are putting the initiative’s…
Blog
Despite medical advancements, maternal mortality rates have doubled since 1987. Yet more than 80% of pregnancy-related deaths have been deemed preventable.We…
Headline
Kimberly Green Reeves, vice president of community impact and partnerships at Beacon Health System, and Cassy White, director of community impact at Beacon…